tiprankstipranks
Trending News
More News >
IBEX (IBEX)
NASDAQ:IBEX
US Market

IBEX (IBEX) Earnings Dates, Call Summary & Reports

Compare
210 Followers

Earnings Data

Report Date
May 20, 2026
After Close (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
0.86
Last Year’s EPS
0.82
Same Quarter Last Year
Based on 2 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Feb 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presents strong operational and financial momentum: record revenue, accelerated EPS growth, improved adjusted EBITDA margins, raised full-year guidance, and clear progress in high-growth verticals (notably HealthTech), offshore expansion and AI capabilities. Lowlights are manageable and largely reflect intentional, growth-oriented investments (higher CapEx, India expansion, and temporary training revenue timing) and a sharp decline in the telecommunications vertical. On balance, the positives and upward guidance significantly outweigh the negatives.
Company Guidance
IBEX raised full-year revenue guidance to $620–$630 million (from $605–$620 million) and lifted adjusted EBITDA guidance to $80–$82 million (from $78–$81 million), and said it now expects capital expenditures at the upper end of its prior $20–$25 million range (i.e., roughly $25M); management also noted HealthTech is on track to be ~$100 million by year‑end, expects an effective tax rate (before discrete items) of about 20–22% for the remaining quarters, and expects DSOs to remain in the mid‑70s. For context, Q2 revenue was $164.2M (up 16.7% YoY), adjusted EBITDA was a record $20.7M (12.6% of revenue), free cash flow was an outflow of $5.1M in the quarter, net cash was ~$14M, weighted average diluted shares were 14.7M, and $7.8M remained on the share repurchase authorization.
Record Quarterly Revenue and Continued Double-Digit Growth
Q2 revenue of $164.2M, up 16.7% year-over-year (CEO cited ~17%). This marks the fourth consecutive quarter of double-digit organic revenue growth and builds on calendar-year 2025 results that surpassed $600M in revenue with 16% growth.
Strong EPS and Profitability Expansion
GAAP diluted EPS of $0.83, up ~45% from $0.57; non-GAAP diluted EPS of $0.87, up 46% from $0.59. Net income rose to $12.2M from $9.3M. Adjusted EBITDA reached a record $20.7M (12.6% of revenue) versus $16.5M (11.8% prior), an ~25.5% increase in adjusted EBITDA and an 80 basis point margin improvement. SG&A decreased from 18.3% to 16.8% of revenue, providing operating leverage.
High-Margin Vertical and Service Outperformance
HealthTech grew 35.1% and increased to 17.4% of revenue (from 15.1%). Travel, transportation & logistics grew 20.2% (now 14.1% of revenue). Retail & e-commerce grew 17.2% and remains ~28.6% of revenue. Higher-margin digital and omnichannel services grew 19% and now represent 82% of total revenue.
Favorable Geographic Mix and Offshore Expansion
Offshore revenues comprised 52.3% of total revenue; highest-margin offshore revenues grew 16.2% YoY. Onshore grew 27.5% (driven by digital acquisition services) and nearshore grew 8.5%. Strategic India expansion (entered March 2025) now operating 2 sites with nearly 1,000 agents, supporting growth in healthcare-related services.
Raised Full-Year Guidance and Strong Net Cash Position
FY26 revenue guidance raised to $620M–$630M (from $605M–$620M). Adjusted EBITDA guidance raised to $80M–$82M (from $78M–$81M). Quarter-end cash $15.5M, debt $1.4M, net cash ~$14M (consistent with prior year-end), providing capacity for investments.
Advancement in AI Capabilities and Talent
Company positions itself as an AI leader with Wave iX (client-facing AI agents and internal AI across agent lifecycle). Senior leadership investment includes promotion of Chief AI & Digital Officer; management is investing in AI, sales resources and capacity to extend differentiation.

IBEX (IBEX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IBEX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 20, 2026
2026 (Q3)
0.85 / -
0.82
Feb 05, 2026
2026 (Q2)
0.79 / 0.87
0.5947.46% (+0.28)
Nov 06, 2025
2026 (Q1)
0.73 / 0.90
0.5273.08% (+0.38)
Sep 11, 2025
2025 (Q4)
0.70 / 0.87
0.5850.00% (+0.29)
May 08, 2025
2025 (Q3)
0.74 / 0.82
0.717.14% (+0.12)
Feb 06, 2025
2025 (Q2)
0.51 / 0.59
0.4434.09% (+0.15)
Nov 07, 2024
2025 (Q1)
0.47 / 0.52
0.430.00% (+0.12)
Sep 12, 2024
2024 (Q4)
0.53 / 0.58
0.3375.76% (+0.25)
May 09, 2024
2024 (Q3)
0.52 / 0.70
0.5918.64% (+0.11)
Feb 08, 2024
2024 (Q2)
0.50 / 0.44
0.62-29.03% (-0.18)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IBEX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 05, 2026
$34.21
Nov 06, 2025
$36.86$36.85-0.03%
Sep 11, 2025
$30.46$41.58+36.51%
May 08, 2025
$25.66$30.55+19.06%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does IBEX (IBEX) report earnings?
IBEX (IBEX) is schdueled to report earning on May 20, 2026, After Close (Confirmed).
    What is IBEX (IBEX) earnings time?
    IBEX (IBEX) earnings time is at May 20, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IBEX EPS forecast?
          IBEX EPS forecast for the fiscal quarter 2026 (Q3) is 0.86.